Evidence map›Paper›PMID 32069316›Full record

ArticlePLoS biology2020

Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases.

Robin A Welsh, Nianbin Song, Catherine A Foss, Tatiana Boronina, Robert N Cole, Scheherazade Sadegh-Nasseri

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes.Molecular & cellular proteomics : MCP · 2022
    Article
  10. Article
  11. Genetic and immunological contributors to virus-induced paralysis.Brain, behavior, & immunity - health · 2021
    Article
  12. MHC Class II Presentation Is Affected by Polymorphism in theJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Robin A WelshGraduate Program in Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Nianbin SongGraduate Program in Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Catherine A FossRussel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0001-8870-5993
Tatiana BoroninaMass Spectrometry and Proteomics Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0001-5270-3849
Robert N ColeMass Spectrometry and Proteomics Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0002-3096-4754
Scheherazade Sadegh-NasseriGraduate Program in Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0002-8127-1720
Johns Hopkins University · US

Funding

Role of DM in Generation of Immunodominant Epitope(s)R01AI063764 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2006 to 2015
$3.6M
Unconventional Sources of Peptides for Antigen PresentationR01AI121174 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SADEGH-NASSERI, SCHEHERAZADE · 2017 to 2022
$2.7M
Understanding the Impacts of HLA-DO in vivoR01AI120634 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2016 to 2019
$1.6M
Molecular Mechanisms of HLA-DO in Antigen ProcessingR21AI101987 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2012 to 2013
$433k
NIAID NIH HHS R01 AI063764NIAID NIH HHS R01 AI120634NIAID NIH HHS R01 AI121174NIAID NIH HHS R21 AI101987
6 · The paper itself

Abstract

DO (HLA-DO, in human; murine H2-O) is a highly conserved nonclassical major histocompatibility complex class II (MHC II) accessory molecule mainly expressed in the thymic medulla and B cells. Previous reports have suggested possible links between DO and autoimmunity, Hepatitis C (HCV) infection, and cancer, but the mechanism of how DO contributes to these diseases remains unclear. Here, using a combination of various in vivo approaches, including peptide elution, mixed lymphocyte reaction, T-cell receptor (TCR) deep sequencing, tetramer-guided naïve CD4 T-cell precursor enumeration, and whole-body imaging, we report that DO affects the repertoire of presented self-peptides by B cells and thymic epithelium. DO induces differential effects on epitope presentation and thymic selection, thereby altering CD4 T-cell precursor frequencies. Our findings were validated in two autoimmune disease models by demonstrating that lack of DO increases autoreactivity and susceptibility to autoimmune disease development.

Indexed as

AnimalsAntigen-Presenting CellsAutoimmune DiseasesAutoimmunityB-LymphocytesCD4-Positive T-LymphocytesCollagenDisease Models, AnimalGenetic Predisposition to DiseaseHistocompatibility Antigens Class IIMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMyelin-Oligodendrocyte GlycoproteinPeptidesCollagenH-2O antigenHistocompatibility Antigens Class IIMyelin-Oligodendrocyte GlycoproteinPeptides

Identifiers

PMID32069316
PMCPMC7028248
OpenAlexW3008336151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.